Summit Creek Advisors LLC cut its holdings in LHC Group, Inc. (NASDAQ:LHCG – Get Rating) by 22.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 132,567 shares of the health services provider’s stock after selling 38,025 shares during the period. LHC Group comprises 2.5% of Summit Creek Advisors LLC’s holdings, making the stock its 18th largest holding. Summit Creek Advisors LLC owned approximately 0.42% of LHC Group worth $22,351,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Invesco Ltd. grew its holdings in LHC Group by 20.2% during the 4th quarter. Invesco Ltd. now owns 1,303,802 shares of the health services provider’s stock valued at $178,922,000 after purchasing an additional 219,148 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in LHC Group by 45.7% in the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 971,349 shares of the health services provider’s stock worth $133,298,000 after acquiring an additional 304,456 shares in the last quarter. Versor Investments LP bought a new position in LHC Group in the 1st quarter worth about $107,058,000. Geneva Capital Management LLC grew its stake in LHC Group by 2.2% in the 1st quarter. Geneva Capital Management LLC now owns 585,587 shares of the health services provider’s stock worth $98,730,000 after acquiring an additional 12,595 shares in the last quarter. Finally, Victory Capital Management Inc. grew its stake in LHC Group by 31.4% in the 4th quarter. Victory Capital Management Inc. now owns 549,228 shares of the health services provider’s stock worth $75,371,000 after acquiring an additional 131,305 shares in the last quarter. 89.65% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have commented on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of LHC Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $190.00 to $170.00 in a research note on Monday, April 25th. Barclays upped their price target on shares of LHC Group from $154.00 to $170.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 12th. Twelve analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $167.33.
LHC Group Trading Up 0.0 %
LHC Group (NASDAQ:LHCG – Get Rating) last posted its quarterly earnings results on Wednesday, May 4th. The health services provider reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The business had revenue of $571.50 million during the quarter, compared to analysts’ expectations of $573.10 million. LHC Group had a net margin of 3.20% and a return on equity of 8.88%. The business’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the company posted $1.39 earnings per share. On average, analysts forecast that LHC Group, Inc. will post 5.84 earnings per share for the current year.
LHC Group Company Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).
- Get a free copy of the StockNews.com research report on LHC Group (LHCG)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.